Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 133

Sort by

Sort Order Select

Journal Articles

Molecular Treatment Stratification for Newly Diagnosed High-Risk Myeloma, Including Plasma Cell Leukemia - Feasibility Results of the Ukmra Optimum: MUK9 Trial (NCT03188172)

Matthew Jenner, MBBS, MRCP, FRCPath, Amy L Sherborne, PhD, Andrew Hall, Vallari Shah, Katrina Walker, Sidra Ellis, Kim Sharp, Amy Price, James Croft, MBBS, BSc, Graham Jackson, MA, MB BS, FRCP, FRCPath, MD, Louise Flanagan, PhD, Mark T Drayson, MB ChB, PhD FRCPath, Ruth M De Tute, BSc,MSc, Roger G. Owen, MD, Guy Pratt, Gordon Cook, Sarah R Brown, PhD MSc, BSc, Martin F. Kaiser

Blood (2019) 134 (Supplement_1): 3162.

https://doi.org/10.1182/blood-2019-123547

Published: 2019

Journal Articles

Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study

Sheri Skerget, PhD, Austin Christofferson, BSc, Sara Nasser, PhD, Christophe Legendre, PhD, The MMRF CoMMpass Network, Jennifer Yesil, Daniel Auclair, Sagar Lonial, Jonathan J Keats, PhD

Blood (2019) 134 (Supplement_1): 1782.

https://doi.org/10.1182/blood-2019-130697

Published: 2019

Journal Articles

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Ayman Qasrawi, MD, Richard L O'Neal, MD, Maxwell M. Krem, MD PhD, Gregory Monohan, MD, Reinhold Munker, MD, Gerhard C. Hildebrandt, MD

Blood (2019) 134 (Supplement_1): 4735.

https://doi.org/10.1182/blood-2019-127687

Published: 2019

Journal Articles

PARP1-Mediated Alt-NHEJ Repair Is a Therapeutic Target in Multiple Myeloma

Daniele Caracciolo, MD, Giada Juli, PhD, Francesca Scionti, PhD, Gaetanina Golino, PhD, Mariamena Arbitrio, MD, Emanuela Altomare, PhD, Katia Todoerti, PhD, Katia Grillone, PhD, Maria Teresa Di Martino, PhD, Marco Rossi, MD, Antonino Neri, MD, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2019) 134 (Supplement_1): 3107.

https://doi.org/10.1182/blood-2019-128245

Published: 2019

Journal Articles

Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs

Guldane Cengiz Seval, Isinsu Kuzu, Seher Yuksel, Gulsah Kaygusuz, Klara Dalva, MD, Muhit Ozcan, Meral Beksac, MD

Blood (2019) 134 (Supplement_1): 3197.

https://doi.org/10.1182/blood-2019-127541

Published: 2019

Journal Articles

Tryptophan Deprivation Promotes an Adaptive Response and Contributes to Bioenergetics in Multiple Myeloma

Alessandra Romano, MDPhD, Nunziatina Laura Parrinello, Katia Todoerti, PhD, Piera La Cava, Fabrizio Puglisi, Cesarina Giallongo, PhD, Daniele Tibullo, Giuseppina Camiolo, Giuseppe Sapienza, MD, Vittorio Del Fabro, MD, Concetta Conticello, Francesco Piazza, Marilena Carrino, PhD, Giuseppe A. Palumbo, MD, Simone Cenci, MD, Antonino Neri, MD, Francesco Di Raimondo, MD

Blood (2018) 132 (Supplement 1): 4511.

https://doi.org/10.1182/blood-2018-99-116447

Published: 2018

Journal Articles

Exosome-Transmitted PSMA3 and PSMA3-AS1 Promotes Proteasome Inhibitors Resistance in Multiple Myeloma

Wenzhuo Zhuang, MD PhD, Sha Song, Huiying Han, Gao Fan, Nengjun Yi, Chenao Qian, Bingzong Li, MD PhD

Blood (2018) 132 (Supplement 1): 4434.

https://doi.org/10.1182/blood-2018-99-110092

Published: 2018

Journal Articles

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

Mengyao Wang, MD, Ying Qu, PhD, Zhiyong Qian, PhD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 4181.

https://doi.org/10.1182/blood-2018-99-119151

Published: 2018

Journal Articles

JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)

Sham Mailankody, MBBS, Myo Htut, MD, Kelvin P. Lee, MD, William Bensinger, MD, Todd Devries, PhD, Julia Piasecki, BA, Safiyyah Ziyad, PhD, Michelle Blake, PhD, John Byon, MDPhD, Andrzej Jakubowiak, MD PhD

Blood (2018) 132 (Supplement 1): 957.

https://doi.org/10.1182/blood-2018-99-113548

Published: 2018

Journal Articles

Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma

Blood (2018) 132 (Supplement 1): 5632.

https://doi.org/10.1182/blood-2018-99-115266

Published: 2018

Journal Articles

Plasma Cell Leukemia - a Single Center Experience

Diana Mota, MD, Adriana Roque, MD, Ana Luísa Pinto, MD, Catarina Geraldes, MD PhD, Jose Pedro Carda, MD, Marília Gomes, MD, Emília Cortesão, MD PhD, José Carlos Almeida, MD, Luis Francisco Araújo, MD, Ana Isabel Espadana, MD, Maria Leticia Ribeiro, MD PhD

Blood (2018) 132 (Supplement 1): 5606.

https://doi.org/10.1182/blood-2018-99-117341

Published: 2018

Journal Articles

Plasma Cell Dyscrasias in HIV, Epidemiology, Presentation and Treatment Characteristics and Its Strong Association with Hepatitis C- Report Form a Large HIV Cohort

Nishi Shah, MBBS, MPH, Sakshi Jasra, MD, Ana Acuna-Villaorduna, MD, Urvi A Shah, MD, Gurbakhash Kaur, MD MA,BS, Mohammad Kazemi, Ioannis Mantzaris, MD MS, Aditi Shastri, MD, Olga Derman, MD, Noah Kornblum, MD, Ira Braunschweig, MD, Amit Verma, MD, Murali Janakiram, MD MS

Blood (2018) 132 (Supplement 1): 5607.

https://doi.org/10.1182/blood-2018-99-119222

Published: 2018

Journal Articles

Dysregulated Translational Control Is a Central Feature of MM Mediated By 14-3-3ε Interactome Promoting Multiple Myeloma Cell Growth and Viability

Blood (2018) 132 (Supplement 1): 3176.

https://doi.org/10.1182/blood-2018-99-118994

Published: 2018

Journal Articles

The Mutational Landscape of Primary Plasma Cell Leukemia

Carolina D. Schinke, MD, Cody Ashby, PhD, Yan Wang, Ruslana G. Tytarenko, MS, Eileen Boyle, Christopher Wardell, PhD, Pingping Qu, Sharmilan Thanendrarajan, MD, Sandra Susanibar, MD, Naveen Yarlagadda, MD, Maliha Khan, Meera Mohan, MD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Faith E. Davies, MD, Bart Barlogie, MD PhD, Gareth Morgan, MD, Brian A Walker, PhD

Blood (2018) 132 (Supplement 1): 114.

https://doi.org/10.1182/blood-2018-99-116758

Published: 2018

Journal Articles

Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

Damian J. Green, MD, Margot Pont, PhD, Blythe Duke Sather, PhD, Andrew J. Cowan, MD, Cameron J. Turtle, MBBS, PhD, Brian G. Till, MD, Anne M Nagengast, RN, Edward N. Libby, III, MD, Pamela S. Becker, MD, David G. Coffey, MD, Sherilyn A. Tuazon, MD, Brent Wood, MD PhD, Michelle Blake, PhD, Melissa Works, PhD, Bruce S Thompson, PhD, Ted Gooley, PhD, Frederick R. Appelbaum, MD, David G. Maloney, MD PhD, Stanley R. Riddell, MD

Blood (2018) 132 (Supplement 1): 1011.

https://doi.org/10.1182/blood-2018-99-117729

Published: 2018

Journal Articles

Genetic Modulation of Adenosine-to-Inosine RNA Editing Selectively Disrupts Inflammasome and Extracellular Matrix Genes in Multiple Myeloma

Leslie A Crews, PhD, Phoebe Mondala, BS, Elisa Lazzari, PhD, Gabriel Pineda, PhD, Christina Wu, PhD, Caitlin L. Costello, MD, Catriona Jamieson, MD PhD

Blood (2018) 132 (Supplement 1): 1324.

https://doi.org/10.1182/blood-2018-99-120326

Published: 2018

Journal Articles

PCL mimicking vHCL: a rare morphological variant

Biswadip Hazarika, Rajive Kumar

Blood (2018) 132 (9): 977.

https://doi.org/10.1182/blood-2018-05-851485

Published: 2018

Journal Articles

Preclinical Evaluation of MEDI2228, a BCMA-Targeting Pyrrolobenzodiazepine-Linked Antibody Drug Conjugate for the Treatment of Multiple Myeloma

Krista Kinneer, John Meekin, Reena Varkey, Xiaodong Xiao, Haihong Zhong, Shannon Breen, Elaine Hurt, Suneetha Thomas, Matt Flynn, Paul Hynes, Binyam Bezabeh, Cui (Tracy) Chen, Leslie Wetzel, Ruoyan Chen, Yu-Tzu Tai, PhD, Kenneth C Anderson, MD, Ronald Herbst, David Tice

Blood (2017) 130 (Supplement 1): 3153.

https://doi.org/10.1182/blood.V130.Suppl_1.3153.3153

Published: 2017

Journal Articles

Primary Plasma Cell Leukemia in China: A Retrospective Single Center Study

Tengteng Yu, Yan Xu, MD, An Gang, MD, Zengjun Li, Mu Hao, PhD, Lugui Qiu, MD

Blood (2017) 130 (Supplement 1): 5428.

https://doi.org/10.1182/blood.V130.Suppl_1.5428.5428

Published: 2017

Journal Articles

Primary Plasma Cell Leukemia: Clinical Profile and Treatment Outcomes of a Rare Disease from Tertiary Cancer Centre from India

Mukul Aggarwal, DM, Neha Yadav, BDS , MBA, Jyotsna Kapoor, MSc, Rayaz Ahmed, MDDM, Narendra Agrawal, MD DM, Priyanka Verma, MD, Pragya Bhandari, MD, Dinesh Bhurani, MD DM, FRCPA

Blood (2017) 130 (Supplement 1): 5400.

https://doi.org/10.1182/blood.V130.Suppl_1.5400.5400

Published: 2017

NARROW

Molecular Treatment Stratification for Newly Diagnosed High-Risk Myeloma, Including Plasma Cell Leukemia - Feasibility Results of the Ukmra Optimum: MUK9 Trial (NCT03188172)

Molecular Characterization of Bone Marrow and Peripheral Blood Compartments from Patients with Plasma Cell Leukemia in the Mmrf Commpass Study

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

PARP1-Mediated Alt-NHEJ Repair Is a Therapeutic Target in Multiple Myeloma

Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs

Tryptophan Deprivation Promotes an Adaptive Response and Contributes to Bioenergetics in Multiple Myeloma

Exosome-Transmitted PSMA3 and PSMA3-AS1 Promotes Proteasome Inhibitors Resistance in Multiple Myeloma

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)

Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma

Plasma Cell Leukemia - a Single Center Experience

Plasma Cell Dyscrasias in HIV, Epidemiology, Presentation and Treatment Characteristics and Its Strong Association with Hepatitis C- Report Form a Large HIV Cohort

Dysregulated Translational Control Is a Central Feature of MM Mediated By 14-3-3ε Interactome Promoting Multiple Myeloma Cell Growth and Viability

The Mutational Landscape of Primary Plasma Cell Leukemia

Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

Genetic Modulation of Adenosine-to-Inosine RNA Editing Selectively Disrupts Inflammasome and Extracellular Matrix Genes in Multiple Myeloma

PCL mimicking vHCL: a rare morphological variant

Preclinical Evaluation of MEDI2228, a BCMA-Targeting Pyrrolobenzodiazepine-Linked Antibody Drug Conjugate for the Treatment of Multiple Myeloma

Primary Plasma Cell Leukemia in China: A Retrospective Single Center Study

Primary Plasma Cell Leukemia: Clinical Profile and Treatment Outcomes of a Rare Disease from Tertiary Cancer Centre from India

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only